李苏宜.营养不良肿瘤患者抗肿瘤药物治疗临床建议路径[J].肿瘤学杂志,2022,28(12):988-990.
营养不良肿瘤患者抗肿瘤药物治疗临床建议路径
Recommendation on Clinical Pathway for Antitumor Drug Therapy in Patients with Malnutrition
投稿时间:2022-08-26  
DOI:10.11735/j.issn.1671-170X.2022.12.B002
中文关键词:  恶性肿瘤  营养不良  抗肿瘤药物治疗  代谢治疗
英文关键词:malignant tumor  malnutrition  antitumor drug therapy  metabolic modulation therapy
基金项目:
作者单位
李苏宜 中国科学技术大学附属第一医院西区(安徽省肿瘤医院) 
摘要点击次数: 482
全文下载次数: 93
中文摘要:
      摘 要:恶性肿瘤住院患者营养不良发生率高且重度营养不良多见。肿瘤患者发生营养不良严重影响患者生活质量,降低抗肿瘤治疗耐受性。抗肿瘤药物治疗是最重要的打击肿瘤病灶的方法之一。为保证实施营养不良肿瘤患者抗肿瘤药物治疗有效性与安全性,建立本临床诊疗路径,从而为临床医师提供营养不良患者抗肿瘤药物治疗的可行性和规范性流程。
英文摘要:
      Abstract: The incidence of malnutrition is high in hospitalized patients with malignant tumors, and severe malnutrition is common. Malnutrition in cancer patients may has a serious impact on quality of life and interfere with the cancer therapy. Antitumor drug therapy is one of the most important ways to attack tumor lesions. In order to ensure the efficacy and safety of antitumor treatments for patients with malnutrition, we developed this suggested clinical diagnosis and treatment pathway, aims to provide clinicians with a feasible and standardized antitumor drug therapy for patients with malnutrition.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器